The best indicator for Corpay (CPAY)
We backtested 366 indicators across daily, weekly and hourly charts on real Corpay (CPAY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
MA Envelope
On the weekly chart, this is the strongest risk-adjusted edge we found for Corpay (CPAY) over ~15.5 years — trailing buy-and-hold by 5.0% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Corpay (CPAY) — trailing buy-and-hold by 11.4% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | MA Envelope ✓ | Weekly | 12.5% | 0.69 | -34.0% | 67.5% | 40 | -5.0% |
| 2 | Positive Volume Index ✓ | Daily | 11.1% | 0.67 | -37.6% | 37.5% | 32 | -6.8% |
| 3 | Stochastic ✓ | Weekly | 11.2% | 0.66 | -28.8% | 100.0% | 15 | -6.3% |
| 4 | Detrended Price Osc. ✓ | Weekly | 12.3% | 0.66 | -41.0% | 62.1% | 95 | -5.2% |
| 5 | Holy Grail Confluence ✓ | Daily | 11.6% | 0.64 | -39.1% | 76.7% | 30 | -6.3% |
| 6 | Connors RSI ✓ | Daily | 10.7% | 0.64 | -29.8% | 64.0% | 175 | -7.2% |
| 7 | Hammer ✓ | Daily | 6.9% | 0.63 | -18.9% | 63.8% | 94 | -11.1% |
| 8 | TRIX ✓ | Weekly | 10.5% | 0.63 | -29.5% | 66.7% | 18 | -7.1% |
| 9 | Hammer ✓ | Weekly | 7.6% | 0.63 | -25.4% | 78.3% | 23 | -10.0% |
| 10 | Connors RSI-2 ✓ | Daily | 10.3% | 0.62 | -37.8% | 63.8% | 177 | -7.6% |
| 11 | Chande-Kroll Stop (fast) ✓ | Weekly | 13.8% | 0.62 | -39.6% | 53.3% | 45 | -3.7% |
| 12 | Volume Flow Indicator ✓ | Daily | 12.2% | 0.61 | -44.3% | 50.0% | 44 | -5.7% |
| 13 | Keltner 20 Break | Weekly | 4.9% | 0.61 | -17.1% | 64.5% | 31 | -12.7% |
| 14 | Markov Regime ✓ | Daily | 14.9% | 0.61 | -49.1% | 57.9% | 19 | -3.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Corpay (CPAY), MA Envelope on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.